Brief: Fate Therapeutics Appoints Mark Plavsic As Chief Technical Officer
15/06/2021 13:24
June 15 (Reuters) - Fate Therapeutics Inc FATE.O :
* FATE THERAPEUTICS APPOINTS MARK PLAVSIC, DVM, PHD, RAC AS
CHIEF
TECHNICAL OFFICER
Source text for Eikon: ID:nGNXglMMD
Further company coverage: FATE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fate Therapeutics
See all newsBrief: Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial Of FT819 For The Treatment Of Lupus Nephritis
Fate Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Fate Therapeutics Q2 loss narrows as expenses fall, revenue rises
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview